Immunonutrition: Can you be what you eat?

Current Opinion in Gastroenterology

Volumn 19, Issue 2, 2003, Pages 134-139

  Koretz, Ronald L ^a  

^a OLIVE VIEW UCLA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; FISH OIL; GLUTAMINE; NITRIC OXIDE; OMEGA 3 FATTY ACID;

ATOPIC DERMATITIS; BONE MARROW TRANSPLANTATION; CANCER; CITRIC ACID CYCLE; CLINICAL TRIAL; COLON CANCER; CROHN DISEASE; DOWN REGULATION; ENDOTHELIUM CELL; ENTERIC FEEDING; ENTEROCOLITIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; INFECTION RATE; MACROPHAGE; NUTRIENT; NUTRITION; NUTRITIONAL SUPPORT; PREMATURITY; REVIEW; SUPPLEMENTATION; TREATMENT INDICATION; ULCERATIVE COLITIS; UPREGULATION;

EID: 0038239254     PISSN: 02671379     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001574-200303000-00006     Document Type: Review

References (53)

1. Studley HO: Percentage of weight loss. A basic indicator of surgical risk in patients with chronic peptic ulcer. JAMA 1936, 106:458-460.
2. Keys A: Caloric deficiency and starvation. In: Jolliffe N, ed. Clinical Nutrition, 2nd ed. New York: Harper and Brothers; 1962:122-136.
3. Rhoads JE, Vars HM, Dudrick SJ: The development of intravenous hyperalimentation. Surg Clin North Am 1981, 61:429-435.
4. Klein S, Kinney J, Jeejeebhoy K, et al.: Nutrition support in clinical practice: review of published data and recommendations for future research directions. JPEN 1997, 21:133-156.
5. Koretz RL, Lipman TO, Klein S: AGA technical review-parenteral nutrition. Gastroenterology 2001, 121:970-1001. A systematic review of the evidence evaluating the efficacy of parenteral nutrition, including a meta-analysis of 82 randomized controlled trials comparing parenteral nutrition with no nutrition support.
6. Koretz RL: Is nutritional support worthwhile? In Consensus in Clinical Nutrition. Edited by Heatley RV, Green JH, Losowsky MS. Cambridge, England: Cambridge University Press; 1994:158-173.
7. Dickson TMC, Wong RM, Negrin RS, et al.: Effect of oral glutamine supplementation during bone marrow transplantation. JPEN 2000, 24:61-66.
8. Koretz RL: Immunonutrition: fact, fantasy, and future. Current Gastroenterology Reports 2002, 4:332-337. A review of the use of two types of immunonutrition, namely the addition of glutamine to parenteral nutrition formulations and the use of the immunonutrient-containing commercial enteral formulations.
9. Ziegler TR, Young LS, Benfell K, et al.: Clinical and metabolic efficacy of glutamine-supplemented parenteral nutrition after bone marrow transplantation. Ann Intern Med 1992, 116:821-828.
10. Schloerb PR, Amare M: Total parenteral nutrition with glutamine in bone marrow transplantation and other clinical applications (a randomized, double-blind study). JPEN 1993, 17:407-413.
11. Van Zaanen HCT, van der Lelie H, Timmer JG, : Parenteral glutamine dipeptide supplementation does not ameliorate chemotherapy-induced toxicity. Cancer 1994, 74:2879-2884.
12. Lacey JM, Crouch JB, Benfell K, et al.: The effects of glutamine-supplemented parenteral nutrition in premature infants. JPEN 1996, 20:74-80.
13. Novak F, Heyland DK, Avenell A, et al.: Glutamine supplementation in serious illness: a systematic review of the evidence. Crit Care Med 2002, 30:2022-2029. A systematic review of the evidence available on assessments of the clinical efficacy of adding glutamine to parenteral or enteral nutrient infusions.
14. Canovas G, Leon-Sanz M, Somi I, et al.: Efficacy of glutamine vs whole protein supplements on gastrointestinal toxicity of high dose chemotherapy in autologous hemopoietic transplant. Clin Nutr 1997, 16 (suppl):33-34.
15. Coghlin Dickson TM, Wong RM, Negrin RS, et al.: Effect of oral glutamine supplementation during bone marrow transplantation. JPEN 2000, 24:61-66.
16. Basu HN, Liepa GU: Arginine: a clinical perspective. Nutr Clin Pract 2002, 17:218-225. A review of arginine and its potential use in surgery, trauma, burns, cardiovascular disease, diabetes, and cancer.
17. Amin HK, Zamora SA, McMillan DD, et al.: Arginine supplementation prevents necrotizing enterocolitis in the premature infant. J Pediatr 2002, 140:425-431.
18. McCarter MD, Gentilini OD, Gomez ME, et al.: Preoperative oral supplement with immunonutrients in cancer patients. JPEN 1998, 22:206-211.
19. Monsoor O, Cornio N, Gillart P, et al.: An arginine enriched enteral nutrition improves nitrogen balance in postoperative patients. Clin Nutr 1997, 16 (Suppl):18.
20. Riso S, Aluffi P, Brugnani M, et al.: Postoperative enteral immunonutrition in head and neck cancer patients. Clin Nutr 2000, 19:407-412.
21. Daly JM, Reynolds J, Thom A, et al.: Immune and metabolic effects of arginine in the surgical patient. Ann Surg 1988, 208:512-523.
22. Sigal RK, Shou J, Daly JM: Parenteral arginine infusion in humans: nutrient substrate or pharmacologic agent? JPEN 1992, 16:423-428.
23. Stechmiller JK, Lentz-Slick A, Bender BS, et al.: Arginine vs protein supplementation in HIV-infected men. Nutr Clin Pract 2001, 16:158-164.
24. Mayser P, Mayer K, Mahloudjian M, et al.: A double-blind, randomized, placebo-controlled trial of n-3 versus n-6 fatty acid-based lipid infusion in atopic dermatitis. JPEN 2002, 26:151-158.
25. Bjorneboe A, Soyland E, Bjorneboe G-EA, et al.: Effect of n-3 fatty acid supplement to patients with atopic dermatitis. J Intern Med 1989, 225 (suppl 1):233-236.
26. Gogos CA, Ginopoulos P, Salsa B, et al.: Dietary omega-3 polyunsaturated fatty acids plus vitamin E restore immunodeficiency and prolong survival for severely ill patients with generalized malignancy. Cancer 1998, 82:395-402.
27. Donadio JV, Bergstralh EJ, Offord KP, et al.: A controlled trial of fish oil in IgA nephropathy. N Engl J Med 1994, 331:1194-1199.
28. Homan van der Heide JJ, Bilo HJG, Donker AJM, et al.: The effects of dietary supplementation with fish oil on renal function and the course of early postoperative rejection episodes in cyclosporine-treated renal transplant recipients. Transplantation 1992, 54:257-263.
29. Aslan A, Triadafilopoulos G: Fish oil fatty acid supplementation in active ulcerative colitis: a double-blind, placebo-controlled, crossover study. Am J Gastroenterol 1992, 87:432-437.
30. Stenson WF, Cort D, Rodgers J, et al.: Dietary supplementation with fish oil in ulcerative colitis. Ann Intern Med 1992, 116:609-614.
31. Hawthorne AB, Daneshmend TK, Hawkey CJ, et al.: Treatment of ulcerative colitis with fish oil supplementation: a prospective 12 month randomised controlled trial. Gut 1992, 33:922-928.
32. Varghese TJ, Coomansingh D, Richardson S, et al.: Clinical effect on ulcerative colitis with dietary supplementation by ω-3 fatty acids: a double blind, randomised study. Gastroenterology 2000, 118:A588.
33. Loeschke K, Ueberschaer B, Pietsch A, et al.: N-3 fatty acids only delay early relapse of ulcerative colitis in remission. Dig Dis Sci 1996, 41:2087-2094.
34. Lorenz R, Weber PC, Szimnau P, et al.: Supplementation with n-3 fatty acids from fish oil in chronic inflammatory bowel disease-a randomized, placebo-controlled, double-blind cross-over trial. J Intern Med 1989, 225 (Suppl 1):225-232.
35. Dichi I, Frenhane P, Dichi JB, et al.: Comparison of ω-3 fatty acids and sulfasalazine in ulcerative colitis. Nutrition 2000, 16:87-90.
36. Lorenz-Meyer H, Bauer P, Nicolay C, et al.: Omega-3 fatty acids and low carbohydrate diet for maintenance of remission in Crohn's disease. Scand J Gastroenterol 1996, 31:778-785.
37. Belluzzi A, Brignola C, Campieri M, et al.: Effect of an enteric-coated fish-oil preparation on relapses in Crohn's disease. N Engl J Med 1996, 334:1557-1560.
38. Garrel DR, Razi M, Lariviere F, et al.: Improved clinical status and length of care with low-fat nutrition support in burn patients. JPEN 1995, 19:482-489.
39. Keithley JK, Swanson B, Zeller JM, et al.: Comparison of standard and immune-enhancing oral formulas in asymptomatic HIV-infected persons: a multicenter randomized controlled clinical trial. JPEN 2002, 26:6-14.
40. Suttmann U, Ockenga J, Schneider H, et al.: Weight gain and increased concentrations of receptor proteins for tumor necrosis factor after patients with symptomatic HIV infection received fortified nutrition support. J Am Diet Assoc 1996, 96:565-569.
41. Pichard C, Sudre P, Karsegard V, et al., and the Swiss HIV cohort study: A randomized double-blind controlled study of 6 months of oral nutritional supplementation with arginine and ω-3 fatty acids in HIV-infected patients. AIDS 1998, 12:53-63.
42. Singer P, Katz DP, Askanazi J, et al.: Enteral nutritional support in patients with acquired immune deficiency syndrome (AIDS): effect of impact versus replete. Clin Nutr 1992, 11 (Suppl):88.
43. Clark RH, Feleke G, Din M, et al.: Nutritional treatment for acquired immunedeficiency virus-associated wasting using β-hydroxy β-methylbutyrate, glutamine, and arginine: a randomized, double-blind, placebo-controlled study. JPEN 2000, 24:133-139.
44. Heys SD, Walker LG, Smith I, et al.: Enteral nutritional supplementation with key nutrients in patients with critical illness and cancer. Ann Surg 1999, 229:467-77.
45. Beale RJ, Bryg DJ, Bihari DJ: Immunonutrition in the critically ill: a systematic review of clinical outcome. Crit Care Med 1999, 27:2799-2805.
46. Heyland DK, Novak F, Drover JW, et al.: Should immunonutrition become routine in critically ill patients? JAMA 2001, 286:944-953. A systematic review and meta-analysis of 22 randomized controlled trials, including one unpublished study, that compared commercially available immunonutrient-containing enteral infusions with standard enteral nutrient infusions.
47. Heyland DK. Immunonutrition in the critically ill patient: putting the cart before the horse? Nutr Clin Pract 2002, 17:267-272. A more detailed discussion of the heterogeneity that was encountered in the Heyland et al. meta-analysis [46].
48. Brown RO, Hunt H, Mewatt-Larssen CA, et al.: Comparison of specialized and standard enteral formulas in trauma patients. Pharmacotherapy 1994, 14:314-320.
49. Guy S, Tanzer-Torres G, Palese M, et al.: Does nasoenteral nutritional support reduce mortality after liver transplant? Hepatology 1995, 22:144A
50. Minard G, Kudsk KA, Melton S, et al.: Early versus delayed feeding with an immune-enhancing diet in patients with severe head injuries. JPEN 2000, 24:145-149
51. Heslin MJ, Latkany L, Leung D, et al.: A prospective, randomized trial of early enteral feeding after resection of upper gastrointestinal malignancy. Ann Surg 1997, 226:567-580
52. Gianotti L, Braga M, Nespoli L, et al.: A randomized controlled trial of preoperative oral supplementation with a specialized diet in patients with gastrointestinal cancer. Gastroenterology 2002, 122:1763-1770.
53. Koretz RL: The calorie conundrum. JPEN 2002, 26:182-183.